Can Colestipol Be Co-Prescribed with Zetia (Ezetimibe)?
Yes, colestipol can be co-prescribed with Zetia (ezetimibe), but they must be administered at least 2 hours before or at least 4 hours after the bile acid sequestrant to maintain ezetimibe's efficacy. 1
Critical Timing Requirement
- Ezetimibe must be dosed either ≥2 hours before or ≥4 hours after colestipol administration to avoid significant reduction in ezetimibe bioavailability 2, 1
- Bile acid sequestrants like colestipol bind ezetimibe in the gastrointestinal tract, substantially decreasing its absorption and therapeutic effect 3
- This timing separation is explicitly stated in FDA labeling and major guidelines as essential for maintaining ezetimibe efficacy 1
Evidence Supporting Combination Use
The combination of ezetimibe with bile acid resins is clinically effective when properly timed:
- A prospective study of 40 patients adding ezetimibe to stable bile acid resin regimens demonstrated significant reductions: 18% in total cholesterol, 19% in LDL-C, and 14% in triglycerides (all p ≤0.03), with good tolerability 4
- Another study combining colesevelam (a related bile acid sequestrant) with ezetimibe showed an additional 20% LDL-C reduction compared to monotherapy with either agent (p <0.005), with 10 of 12 patients reaching NCEP ATP III targets 5
Guideline Support
Major lipid guidelines explicitly address this combination:
- The 2022 ACC Expert Consensus recognizes ezetimibe as appropriate adjunctive therapy to diet and can be combined with other lipid-lowering agents 2
- The same guideline specifically notes that when bile acid sequestrants are used with ezetimibe, proper timing separation is mandatory 2
- Ezetimibe is FDA-approved for use in combination with multiple lipid-lowering therapies, though bile acid sequestrants require the timing adjustment 1
Practical Implementation
To successfully combine these medications:
- Morning dosing option: Give ezetimibe in the morning, colestipol at lunch or dinner 1
- Evening dosing option: Give colestipol in the morning, ezetimibe at lunch or evening 1
- Both medications can be taken with or without food, providing flexibility in scheduling 2, 1
- No dosage adjustment of either agent is required when combined, only timing separation 1
Common Pitfall to Avoid
The single most important error is administering these medications simultaneously or too close together, which can reduce ezetimibe's LDL-C lowering effect by approximately 55% based on AUC data 3. This negates the therapeutic benefit of adding ezetimibe and wastes both medication costs and the opportunity for additional LDL-C reduction.
Safety Considerations
- No contraindications exist for combining ezetimibe with bile acid sequestrants beyond the timing requirement 1
- The combination does not increase adverse events compared to either agent alone 4, 5
- Both agents work through complementary mechanisms (ezetimibe blocks intestinal cholesterol absorption; colestipol binds bile acids), providing additive LDL-C lowering without overlapping toxicity 2, 3